What drove the MRU.TO stock drop on Jan 27, 2026?

MRU.TO stock fell after Metro reported Q1 GAAP net income of **C$226.30M**, below last year, with EPS **C$1.05**. Investors reacted to the profit miss and guidance concerns, causing higher intraday volume and selling pressure.

How does Metro's valuation compare to its sector for MRU.TO stock?

MRU.TO stock trades at a trailing PE of **21.24**, below the Consumer Defensive average PE **28.53**. Price-to-book sits near **3.00**. The stock looks relatively cheaper on PE but not a large margin of safety.

What is Meyka AI's forecast and grade for MRU.TO stock?

Meyka AI rates MRU.TO **77.50 (B+, BUY)**. Meyka AI's forecast model projects a yearly price of **C$93.36**, implying about **+1.25%** versus the current **C$92.23**. Forecasts are model-based and not guarantees.

Which catalysts should investors watch for MRU.TO stock?

Watch Metro's earnings call today at **13:30 EST**, management guidance, same-store sales, and pharmacy performance. Any margin commentary or promotional increases will materially affect MRU.TO stock near term.

CA Stocks

MRU.TO stock -7.19% after Q1 miss (Metro Inc TSX) Jan 27, 2026: focus on margins

ByHuzaifa Zahoor January 27, 2026January 27, 2026

MRU.TO stock fell 7.19% intraday to C$92.23 after Metro Inc.’s Q1 release on Jan 27, 2026. The company reported GAAP profit of C$226.30 million (EPS C$1.05), below last year’s C$259.50 million (EPS C$1.16). Revenue rose 3.30% to C$5.285 billion, but investors sold on the profit miss and guidance questions. We review the earnings, valuation, intraday flow, and what to watch next for MRU.TO stock.